Menu
ncarol.com
  • Home
  • Business
  • Financial
  • Stocks
  • Yacht Buyer
  • Nyse
  • Finance
  • Banking
  • Loans
ncarol.com

CCHR Warns of ADHD Drug Risks as WHO Denies Essential Status for Stimulant
ncarol.com/10249596

Trending...
  • Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida
  • Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
  • Off The Hook YS (NY SE: OTH) Executes Transformational Apex Acquisition, Creating Vertically Integrated Marine Powerhouse with $60M Inventory Capacity
3.3 million children are given psychiatric drugs
Mental health industry watchdog discloses that 3.3 million U.S. children are given psychiatric drugs despite WHO disapproving of these for children younger than 12

LOS ANGELES - ncarol.com -- In a recent Lancet Psychiatry article, experts have supported the World Health Organization's decision to withhold essential medicine status from methylphenidate, a drug used for Attention Deficit Hyperactivity Disorder (ADHD). The latest WHO Model List of Essential Medicines (EML) has gone even further by removing the antipsychotics chlorpromazine and haloperidol, and the antidepressant fluoxetine for children. Indeed, "The current EML contains no medications of any kind to treat mental disorders in children younger than 12 years, which aligns with current evidence," Lancet reported.[1] Despite this, the Citizens Commission on Human Rights International says that over 3 million U.S. children aged 12 and younger are prescribed psychiatric drugs, as per statistics from the IQVia Total Patient Tracker database.[2]

IQVia statistics reveal that of the 3.3 million, 1,809,101 are prescribed stimulants for ADHD; 336,125 are prescribed antipsychotics, and 581,979 are prescribed antidepressants—the latter, however, are not indicated in anyone younger than 24 because of the risk of suicide. CCHR said the psychotropic drugging of America's children is shameful and putting them at risk.

Ole Jakob Storebø from the Center for Evidence-Based Psychiatry, Psychiatric Research Unit, Denmark, and colleagues wrote, "WHO indicates that precautions are warranted regarding any pharmacological treatment of mental disorders for children younger than 12 years. From an evidence-based perspective, we believe the precautions to be an ethical and sound stance."

Before their passing, the doctors responsible for putting ADHD on the map were aghast at what they helped create. Child psychiatrist Leon Eisenberg, the "scientific father of ADHD", along with child psychologist Keith Conners, Ph.D., conducted clinical trials on methylphenidate in the 1960s. In 2009, he remorsefully called ADHD a "prime example of a fictitious disease."[3] In 2013, Conners said he was appalled at how many children were saddled with the diagnosis, calling it "a national disaster of dangerous proportion."[4]

In 2015, CCHR notified the UN Committee on the Rights of the Child (UNCRC) of the aggressive worldwide diagnosing of ADHD and stimulants prescribed to children, resulting in UNCRC hearings being held. The agency found that "educational resources and funding systems for practitioners are geared toward a 'quick fix'" and recommended the establishment of a system for "monitoring of the excessive use of psychostimulants to children." It called for governments to "take the necessary measures to prevent any pressure on children and parents to accept treatment with psychostimulant drugs."[5]

More on ncarol.com
  • OpenSSL Corporation Advisory Committees' Elections 2026: Results Announcement
  • Zarova Vodka Expands Its Ultra-Premium Spirits Portfolio Through Strategic Acquisitions
  • If You Had a Legal Case Today — Who Would You Trust Your Legal AI With?
  • François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only
  • UK Financial Ltd Sets February 27 CATEX Debut for VENUS Coin, Opening Limited Early Access Through MayaPro Wallet

In 2018, and again in 2020, the WHO Expert Committee on the selection and use of essential medicines declined to grant the stimulant drug methylphenidate the status of an essential medicine.[6]

The U.S. Drug Enforcement Administration classifies methylphenidate as a high-abuse Schedule II drug, in the same category as morphine, opium and cocaine. A study in the Journal of Neuroscience said it is more potent than cocaine.[7]

Other stimulant side effects include nervousness, insomnia, blood pressure and pulse changes, weight loss, heart attacks, strokes and sudden death, and new or worsening aggression and hostility.[8] Methylphenidate's manufacturer warns it is a drug of dependency.[9] Last year, the Food and Drug Administration acknowledged ADHD drugs can cause addiction, even when used as prescribed, and required this information be added to its black box warning on all stimulant drugs.[10]

Students also abuse these drugs. Researchers at the University of California, San Diego School of Medicine found brain scans of college students who abused stimulants showed impaired neuronal activity. "If you show me 100 college students and tell me which ones have taken stimulants a dozen times, I can tell you those students' brains are different," Dr. Martin Paulus, professor of psychiatry, said.[11]

In a groundbreaking September 2005 study, the Evidence-based Practice Center of Oregon Health & Science University analyzed 2,287 studies, encompassing virtually all research on ADHD drugs. Surprisingly, none of the trials demonstrated the effectiveness of these drugs, and there was insufficient evidence supporting their positive impact on "academic performance, risky behaviors, social achievements, etc."[12]

The anomaly is the American Psychiatric Association admits, "There are no laboratory tests, neurological assessments, or attentional assessments that have been established as diagnostic in the clinical assessment" of ADHD.[13] The diagnosis is largely based on subjective behavioral symptoms, including not sitting still, losing pencils and not finishing chores.

Kelly O'Meara, former Congressional staff and author of Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills That Kill, summed it up: "In essence, what is happening is that millions of American children are being put on mind-altering drugs—the equivalent of cocaine—every day and often for years on end, to treat a mental illness that no one can say with certainty an objective, confirmable abnormality exists. The best and brightest in mental health admit they are speculating—guessing—effectively using America's children as dice in a psychopharmacological crapshoot."[14]

More on ncarol.com
  • Ice Melts. Clean Water Fails. A Startup Thinks It Has the Fix
  • Delay In Federal Disaster Assistance Causing Failure Of Small Business In Disaster Areas
  • Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief
  • When Representation No Longer Reflects the District — Why I'm Voting for Pete Verbica
  • Off The Hook YS (NY SE: OTH) Executes Transformational Apex Acquisition, Creating Vertically Integrated Marine Powerhouse with $60M Inventory Capacity

About CCHR: CCHR was founded in 1969 by the Church of Scientology and the late Dr. Thomas Szasz, Professor of Psychiatry. It has helped achieve over 190 laws to protect the rights of patients within the mental health system.

[1] www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(23)00395-4/fulltext
[2] www.cchrint.org/psychiatric-drugs/people-taking-psychiatric-drugs/
[3] www.cchrint.org/2022/02/14/new-diagnostic-manual-with-adhd-listed-could-turn-childhood-into-a-mental-disorder/
[4] www.cchrint.org/2017/08/23/teen-overdose-deaths-from-adhd-anti-anxiety-drugs-on-the-rise/, citing: www.scientificamerican.com/article/big-pharma-s-manufactured-epidemic-the-misdiagnosis-of-adhd; rss.onlinelibrary.wiley.com/doi/full/10.1111/j.1740-9713.2016.00979.x
[5] www.cchr.org/newsletter/2015-summer-child-drugging-reports-worldwide-abuse.html; www2.ohchr.org/english/bodies/crc/docs/co/crc-c-can-co-3-4_en.pdf; docstore.ohchr.org/SelfServices/FilesHandler.ashx?enc=6QkG1d%2FPPRiCAqhKb7yhskw6ZHlSjLETdRql6Pfo3d19G0fwi7ZPZdEOVKAQgeqWKogX2iXEvcG5O%2BzGKtEo1nvnVtG%2FXYEnmWa47plmDxnXlhPMHh5Fz%2FKc%2FL6gvzos
[6] www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(23)00395-4/fulltext
[7] www.deadiversion.usdoj.gov/drug_chem_info/methylphenidate.pdf; Brian Vastag, "Pay Attention: Ritalin Acts Much Like Cocaine," JAMA, 22/29 Aug. 2001, Vol. 286, No. 5, p. 906
[8] Physicians' Desk Reference, (Medical Economics Company, New Jersey, 1998), pp. 1896-1897; DSM-III, p. 150; PDR.Net, www.pdr.net/drug-summary/?drugLabelId=1003; Ricardo Alonso-Zaldivar, "Warning Urged for ADHD Drugs," Los Angeles Times, Feb. 10, 2005; www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/
[9] www.novartis.com/us-en/sites/novartis_us/files/ritalin_la.pdf
[10] www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/; "FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions," FDA 11 May 2023; www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/
[11] www.counselheal.com/articles/9144/20140326/even-occasional-stimulant-use-dulls-brain.htm
[12] www.counselheal.com/articles/9144/20140326/even-occasional-stimulant-use-dulls-brain.htm
[13] Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, (American Psychiatric Association, Washington D.C. 2000), pp. 88-89
[14] Kelly Patricia O'Meara, Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills that Kill, (AuthorHouse, 2006), p. 75

Contact
Amber Rauscher
***@cchr.org


Source: Citizens Commission on Human Rights

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Wespor Business Launches AI Voice and Chat Agents to Help Triangle Small Businesses Capture Missed Leads
  • America's Boating Club Ushers in New Board at Change of Watch
  • FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
  • $2.7 Million 2025 Revenue; All Time Record Sales Growth; 6 Profitable Quarters for Homebuilding Industry: Innovative Designs (Stock Symbol: IVDN)
  • CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
  • PRÝNCESS Builds Anticipation With "My Nerves" — A Girls-Girl Anthem
  • Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
  • From Sleepless Nights to Sold-Out Drops: Catch Phrase Poet's First Year Redefining Motivational Urban Apparel
  • Cold. Clean. Anywhere. Meet FrostSkin
  • How Specialized Game Development Services Are Powering the Next Wave of Interactive Entertainment
  • Don't Settle for a Lawyer Who Just Speaks Spanish. Demand One Who Understands Your Story
  • Dan Williams Promoted to Century Fasteners Corp. – General Manager, Operations
  • Ski Johnson Inks Strategic Deals with Three Major Food Chain Brands
  • NIL Club Advances Agent-Free NIL Model as Oversight Intensifies Across College Athletics
  • Atlanta Magazine Names Dr. Rashad Richey One of Atlanta's Most Influential Leaders in 2026 as the FIFA World Cup Approaches
  • Apostle Margelee Hylton Announces the Release of Third Day Prayer
  • Slotozilla Reports Strong Q4 Growth and Sigma Rome Success
  • "Lights Off" and Laughs On: Joseph Neibich Twists Horror Tropes in Hilariously Demonic Fashion
  • Families Gain Clarity: Postmortem Pathology Expands Private Autopsy Services in St. Louis
  • Beethoven: Music of Revolution and Triumph - Eroica
_catLbl0 _catLbl1

Popular on ncarol.com

  • Desert Mountain Club Earns Prestigious Blue Zones Approved™ Triple Designation, a New Standard for Well-Being in a Luxury Lifestyle Community - 105
  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies - 102
  • Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments
  • HELM Audio™ Partners with PQCrypto to Future-Proof Children's Hearing and Safety Data Using Post-Quantum Cryptography
  • Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?
  • purelyIV Expands Concierge Wellness Platform with New IV Therapies, Memberships, and Digital Experience
  • CNCPW Divulga Dados de Liquidez do 1º Trimestre: Confirma 100% de Reservas e Atualiza Protocolos de "Saque CNCPW" Contra Fluxos Ilícitos
  • CCHR: Europe Rejects Forced Psychiatry—Landmark Vote Declares Coercive Practices Incompatible with Human Rights
  • Wall Street Is Missing This One: Cycurion (NAS DAQ: CYCU) Gets $7 Price Target While Trading at a Steep Discount
  • Scoop Social Co. Partners with Fairmont Hotels & Resorts to Elevate Summer Guest Experiences with Italian Inspired Gelato & Beverage Carts

Similar on ncarol.com

  • Integris Composites developing armor for military in Arctic Circle
  • Workplace safety ideas from the front lines to highlight Applied Ergonomics Conference in Arlington, Texas
  • Ice Melts. Clean Water Fails. A Startup Thinks It Has the Fix
  • Delay In Federal Disaster Assistance Causing Failure Of Small Business In Disaster Areas
  • Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief
  • When Representation No Longer Reflects the District — Why I'm Voting for Pete Verbica
  • Revolutionary Data Solution Transforms Health Insurance Underwriting Accuracy
  • Art of Whiskey Hosts 3rd Annual San Francisco Tasting Experience During Super Bowl Week
  • Sleep Basil Unveils Revamped Natural Latex Mattress Collection Page for Cooler, Cleaner, Better-Aligned Sleep
  • Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute